A. Markovac

482 total citations
23 papers, 370 citations indexed

About

A. Markovac is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, A. Markovac has authored 23 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 8 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in A. Markovac's work include Synthesis and Characterization of Heterocyclic Compounds (5 papers), Synthesis and biological activity (5 papers) and Synthesis and Biological Evaluation (5 papers). A. Markovac is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (5 papers), Synthesis and biological activity (5 papers) and Synthesis and Biological Evaluation (5 papers). A. Markovac collaborates with scholars based in Canada and United States. A. Markovac's co-authors include M. P. LAMONTAGNE, Bashir Kaskar, Víctor E. Márquez, S. F. MacDonald, Muhammad S. Khan, Christopher K. H. Tseng, Calvin L. Stevens, John S. Driscoll, Peter Blumbergs and Jacqueline Plowman and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Canadian Journal of Chemistry.

In The Last Decade

A. Markovac

22 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Markovac Canada 10 211 165 75 46 39 23 370
Virgil L. Styles United States 8 179 0.8× 120 0.7× 49 0.7× 50 1.1× 17 0.4× 20 315
H. HERBERT FOX United Kingdom 13 207 1.0× 114 0.7× 85 1.1× 70 1.5× 10 0.3× 26 444
Brendan A. Burkett Singapore 12 219 1.0× 255 1.5× 58 0.8× 34 0.7× 35 0.9× 21 546
Stephen Neidle United Kingdom 9 118 0.6× 341 2.1× 31 0.4× 37 0.8× 22 0.6× 9 472
Philip M. Carabateas United States 14 263 1.2× 146 0.9× 45 0.6× 53 1.2× 6 0.2× 35 441
George L. Dunn United States 14 240 1.1× 182 1.1× 36 0.5× 41 0.9× 10 0.3× 24 501
V. S. Bhadti United States 13 425 2.0× 180 1.1× 147 2.0× 58 1.3× 29 0.7× 28 690
Donald F. Worth United States 14 382 1.8× 225 1.4× 32 0.4× 26 0.6× 98 2.5× 48 640
M. P. LAMONTAGNE 11 225 1.1× 88 0.5× 20 0.3× 20 0.4× 70 1.8× 24 317
Gagan Kukreja India 12 401 1.9× 150 0.9× 44 0.6× 31 0.7× 56 1.4× 16 555

Countries citing papers authored by A. Markovac

Since Specialization
Citations

This map shows the geographic impact of A. Markovac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Markovac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Markovac more than expected).

Fields of papers citing papers by A. Markovac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Markovac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Markovac. The network helps show where A. Markovac may publish in the future.

Co-authorship network of co-authors of A. Markovac

This figure shows the co-authorship network connecting the top 25 collaborators of A. Markovac. A scholar is included among the top collaborators of A. Markovac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Markovac. A. Markovac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaskar, Bashir & A. Markovac. (1989). A new synthesis of 2′,3′‐dideoxycytidine. Journal of Heterocyclic Chemistry. 26(6). 1531–1533. 5 indexed citations
2.
Márquez, Víctor E., et al.. (1988). Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties. Journal of Medicinal Chemistry. 31(9). 1687–1694. 69 indexed citations
3.
Márquez, Víctor E., et al.. (1988). Total synthesis of (-)-neplanocin A. The Journal of Organic Chemistry. 53(24). 5709–5714. 68 indexed citations
4.
LAMONTAGNE, M. P., A. Markovac, & Muhammad S. Khan. (1982). Antimalarials. 13. 5-Alkoxy analogs of 4-methylprimaquine. Journal of Medicinal Chemistry. 25(8). 964–968. 30 indexed citations
5.
Markovac, A. & M. P. LAMONTAGNE. (1980). Antimalarials. 12. Preparation of carbon isosteres of selected 4-pyridinemethanols as suppressive antimalarials. Journal of Medicinal Chemistry. 23(11). 1198–1201. 13 indexed citations
6.
Markovac, A., et al.. (1977). 4‐(3‐nitrophenyl)‐2‐pieohne. Journal of Heterocyclic Chemistry. 14(1). 147–148. 1 indexed citations
7.
LAMONTAGNE, M. P., et al.. (1977). Antimalarials. 10. Synthesis of 4-substituted primaquine analogs as candidate antimalarials. Journal of Medicinal Chemistry. 20(9). 1122–1127. 11 indexed citations
8.
Markovac, A., et al.. (1977). Synthesis of oxirnes. IV. 2‐pyridinealdoxime methiodides from 2‐picoline methiodides. Journal of Heterocyclic Chemistry. 14(1). 19–26. 2 indexed citations
9.
LAMONTAGNE, M. P., et al.. (1976). Antimalarials. 8. Synthesis of amino ethers as candidate antimalarials. Journal of Medicinal Chemistry. 19(3). 360–365. 8 indexed citations
10.
Markovac, A. & M. P. LAMONTAGNE. (1976). Antimalarials. 9. Methylthio- and methylsulfonyl-substituted 9-phenanthrenemethanols. Journal of Medicinal Chemistry. 19(7). 978–982. 3 indexed citations
11.
LAMONTAGNE, M. P., A. Markovac, & Peter Blumbergs. (1974). Antimalarials. 6. Synthesis, antimalarial activity, and configurations of racemic .alpha.-(2-piperidyl)-4-pyridinemethanols. Journal of Medicinal Chemistry. 17(5). 519–523. 9 indexed citations
12.
LAMONTAGNE, M. P., A. Markovac, & Min Ao. (1973). Antimalarials. 5. 2-Aryl-6-trifluoromethy-1-4-pyridinemethanols. Journal of Medicinal Chemistry. 16(9). 1040–1041. 4 indexed citations
13.
Markovac, A., et al.. (1972). Antimalarials. 3. 2,6-Bis(aryl)-4-pyridinemethanols with trifluoromethyl substituents. Journal of Medicinal Chemistry. 15(9). 918–922. 9 indexed citations
14.
Markovac, A., et al.. (1972). Antimalarials. 1. 2-Quinolinemethanols. Journal of Medicinal Chemistry. 15(5). 490–493. 1 indexed citations
15.
Blumbergs, Peter, et al.. (1972). Antimalarials. 2. 2,6-Bis(aryl)-4-pyridinemethanols. Journal of Medicinal Chemistry. 15(8). 808–812. 7 indexed citations
16.
Markovac, A., et al.. (1970). Synthesis of oximes. III. Iodine dimethyl sulfoxide reaction with methylpyridines. The Journal of Organic Chemistry. 35(3). 841–843. 21 indexed citations
17.
Markovac, A., et al.. (1966). THE INTERCONVERSION OF 5-CHLORO- AND 5-HYDROXY-DIPYRRYLMETHENES. Canadian Journal of Chemistry. 44(19). 2329–2336. 3 indexed citations
18.
Markovac, A., et al.. (1966). THE SYNTHESIS OF PORPHYRINS DERIVED FROM CHLOROBIUM CHLOROPHYLLS. Canadian Journal of Chemistry. 44(3). 345–362. 20 indexed citations
19.
MacDonald, S. F. & A. Markovac. (1965). HIGHER HOMOLOGUES FROM PYRROLES AND DIPYRRYLMETHENES. Canadian Journal of Chemistry. 43(12). 3247–3252. 6 indexed citations
20.
Markovac, A. & S. F. MacDonald. (1965). SYNTHESES WITH 5-DIBROMOMETHYL- AND 5-FORMYL-PYRROMETHENES. Canadian Journal of Chemistry. 43(12). 3364–3371. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virgil L. Styles Breakdown of academic impact, for papers by H. HERBERT FOX Breakdown of academic impact, for papers by Brendan A. Burkett Breakdown of academic impact, for papers by Stephen Neidle Breakdown of academic impact, for papers by Philip M. Carabateas Breakdown of academic impact, for papers by George L. Dunn Breakdown of academic impact, for papers by V. S. Bhadti Breakdown of academic impact, for papers by Donald F. Worth Breakdown of academic impact, for papers by M. P. LAMONTAGNE Breakdown of academic impact, for papers by Gagan Kukreja
Rankless by CCL
2026